Human epidermal growth factor receptor 2 (HER2) is widely recognized as an effective target for targeted therapy in colorectal cancer (Suwaidan et al., 2022); however, its role in the context of conventional chemotherapy has received limited investigation. The gene discussed is ERBB2; the disease is colorectal cancer.